KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

GoodRx Holdings (GDRX) Accumulated Depreciation & Amortization (2019 - 2025)

GoodRx Holdings' Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $22.3 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 22.27% year-over-year to $22.3 million; the TTM value through Dec 2025 reached $22.3 million, up 22.27%, while the annual FY2025 figure was $22.3 million, 22.27% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $22.3 million at GoodRx Holdings, up from $18.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $22.3 million in Q4 2025 and bottomed at $5.8 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $13.8 million (2023), against an average of $14.0 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 173.66% in 2021 before it rose 22.27% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $5.8 million in 2021, then skyrocketed by 67.59% to $9.8 million in 2022, then surged by 41.12% to $13.8 million in 2023, then surged by 32.24% to $18.2 million in 2024, then rose by 22.27% to $22.3 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Accumulated Depreciation & Amortization are $22.3 million (Q4 2025), $18.2 million (Q4 2024), and $13.8 million (Q4 2023).